1. Studies on di- and triterpenoids from Salvia staminea with cytotoxic activity.
- Author
-
Topcu G, Altiner EN, Gozcu S, Halfon B, Aydogmus Z, Pezzuto JM, Zhou BN, and Kingston DG
- Subjects
- Antineoplastic Agents administration & dosage, Antineoplastic Agents chemistry, Antineoplastic Agents therapeutic use, Diterpenes administration & dosage, Diterpenes chemistry, Diterpenes therapeutic use, Humans, Inhibitory Concentration 50, Plant Extracts administration & dosage, Plant Extracts chemistry, Plant Extracts therapeutic use, Triterpenes administration & dosage, Triterpenes chemistry, Triterpenes therapeutic use, Tumor Cells, Cultured drug effects, Antineoplastic Agents pharmacology, Diterpenes pharmacology, Phytotherapy, Plant Extracts pharmacology, Salvia, Triterpenes pharmacology, Yeasts drug effects
- Abstract
A new ursane-type triterpenoid, 3 beta,11 alpha,21 alpha-trihydroxyurs-12-ene, named salvistamineol (1), has been isolated from the methanol extract of Salvia staminea. In addition to 1, the methanol extract yielded four known compounds and the acetone extract yielded twelve known compounds consisting of two sesquiterpenes, six diterpenoids, a triterpenoid, two steroids and one flavone. DNA damaging properties of the extracts and some isolated diterpenes were investigated against three yeasts and only taxodione gave a positive response and also showed the highest cytotoxic activity against a panel of cell lines among the investigated compounds in this study.
- Published
- 2003
- Full Text
- View/download PDF